CROSS CTRY HEALTHCARE INC's ticker is CCRN and the CUSIP is 227483104. A total of 124 filers reported holding CROSS CTRY HEALTHCARE INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $7,165,868 | -18.9% | 517,765 | +9.7% | 0.00% | 0.0% |
Q1 2024 | $8,839,210 | +2.1% | 472,180 | +23.4% | 0.00% | 0.0% |
Q4 2023 | $8,660,095 | -37.4% | 382,513 | -31.5% | 0.00% | -50.0% |
Q3 2023 | $13,840,307 | -10.1% | 558,302 | +1.8% | 0.00% | 0.0% |
Q2 2023 | $15,392,473 | +28.9% | 548,165 | +2.5% | 0.00% | +33.3% |
Q1 2023 | $11,939,057 | -18.8% | 534,904 | -3.4% | 0.00% | -25.0% |
Q4 2022 | $14,709,445 | -47.1% | 553,611 | -43.5% | 0.00% | -55.6% |
Q3 2022 | $27,794,000 | +53.2% | 979,690 | +12.5% | 0.01% | +80.0% |
Q2 2022 | $18,139,000 | +33.5% | 870,849 | +38.9% | 0.01% | +66.7% |
Q1 2022 | $13,589,000 | -26.1% | 627,068 | -5.4% | 0.00% | -25.0% |
Q4 2021 | $18,399,000 | +28.3% | 662,776 | -1.8% | 0.00% | 0.0% |
Q3 2021 | $14,338,000 | +42.7% | 675,072 | +10.9% | 0.00% | +100.0% |
Q2 2021 | $10,051,000 | +78.4% | 608,819 | +35.0% | 0.00% | 0.0% |
Q1 2021 | $5,633,000 | +65.0% | 450,971 | +17.2% | 0.00% | +100.0% |
Q4 2020 | $3,414,000 | +61.6% | 384,887 | +18.2% | 0.00% | 0.0% |
Q3 2020 | $2,113,000 | -3.5% | 325,537 | -8.4% | 0.00% | 0.0% |
Q2 2020 | $2,189,000 | -6.8% | 355,317 | +2.0% | 0.00% | 0.0% |
Q1 2020 | $2,348,000 | -45.7% | 348,347 | -6.3% | 0.00% | 0.0% |
Q4 2019 | $4,321,000 | -25.6% | 371,871 | -34.1% | 0.00% | -50.0% |
Q3 2019 | $5,811,000 | +16.6% | 564,191 | +6.2% | 0.00% | +100.0% |
Q2 2019 | $4,985,000 | +20.8% | 531,439 | -9.5% | 0.00% | 0.0% |
Q1 2019 | $4,127,000 | -6.0% | 586,997 | -2.0% | 0.00% | -50.0% |
Q4 2018 | $4,389,000 | -16.7% | 598,781 | -0.7% | 0.00% | 0.0% |
Q3 2018 | $5,267,000 | +23.6% | 603,285 | +59.2% | 0.00% | +100.0% |
Q2 2018 | $4,263,000 | +94.6% | 378,972 | +92.1% | 0.00% | 0.0% |
Q1 2018 | $2,191,000 | +27.8% | 197,230 | +46.7% | 0.00% | 0.0% |
Q4 2017 | $1,715,000 | -1.5% | 134,413 | +9.8% | 0.00% | 0.0% |
Q3 2017 | $1,742,000 | +21.5% | 122,403 | +10.2% | 0.00% | – |
Q2 2017 | $1,434,000 | -11.1% | 111,100 | -1.1% | 0.00% | -100.0% |
Q1 2017 | $1,613,000 | -2.7% | 112,302 | +5.8% | 0.00% | 0.0% |
Q4 2016 | $1,657,000 | +25.6% | 106,169 | -5.2% | 0.00% | – |
Q3 2016 | $1,319,000 | -13.2% | 111,989 | +2.5% | 0.00% | -100.0% |
Q2 2016 | $1,520,000 | -16.9% | 109,215 | -30.6% | 0.00% | 0.0% |
Q1 2016 | $1,830,000 | -56.8% | 157,393 | -39.1% | 0.00% | -50.0% |
Q4 2015 | $4,233,000 | +23.7% | 258,246 | +2.7% | 0.00% | +100.0% |
Q3 2015 | $3,423,000 | +150.0% | 251,527 | +133.0% | 0.00% | 0.0% |
Q2 2015 | $1,369,000 | +9.9% | 107,969 | +2.8% | 0.00% | – |
Q1 2015 | $1,246,000 | -13.4% | 105,075 | -8.8% | 0.00% | -100.0% |
Q4 2014 | $1,438,000 | +26.6% | 115,236 | -5.8% | 0.00% | – |
Q3 2014 | $1,136,000 | +39.4% | 122,305 | -2.2% | 0.00% | – |
Q2 2014 | $815,000 | -27.2% | 125,059 | -9.8% | 0.00% | – |
Q1 2014 | $1,120,000 | -30.1% | 138,685 | -13.6% | 0.00% | -100.0% |
Q4 2013 | $1,602,000 | +71.9% | 160,531 | +4.0% | 0.00% | – |
Q3 2013 | $932,000 | +60.1% | 154,292 | +36.8% | 0.00% | – |
Q2 2013 | $582,000 | – | 112,803 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Simcoe Capital Management, LLC | 1,143,625 | $23,822,000 | 3.28% |
SYSTEMATIC FINANCIAL MANAGEMENT LP | 2,194,340 | $45,708,000 | 1.59% |
INVESTMENT MANAGEMENT OF VIRGINIA LLC | 704,526 | $14,676,000 | 1.51% |
Mesirow Financial Investment Management, Inc. | 12,643 | $263,000 | 1.27% |
Aristotle Capital Boston, LLC | 1,638,612 | $34,132,000 | 1.02% |
Zebra Capital Management LLC | 14,351 | $299,000 | 0.88% |
Alpha DNA Investment Management LLC | 49,398 | $1,028,000 | 0.88% |
SummerHaven Investment Management, LLC | 55,577 | $1,158,000 | 0.78% |
GLOBEFLEX CAPITAL L P | 145,700 | $3,035,000 | 0.74% |
OBERWEIS ASSET MANAGEMENT INC/ | 96,900 | $2,018,000 | 0.51% |